Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets
Hsu M, Jung O, Kwan L, Jegede O, Martin B, Malhotra A, Suzuki J. Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets. Journal Of Substance Use And Addiction Treatment 2023, 157: 209216. PMID: 37981243, DOI: 10.1016/j.josat.2023.209216.Peer-Reviewed Original ResearchOpioid use disorderSocioeconomic statusUse disordersCOVID-19 pandemicBuprenorphine/naloxoneActive substance useUse disorder treatmentPercent of participantsActive prescriptionMOUD accessSublingual buprenorphineOUD treatmentTreatment gapTreatment accessMOUDDisorder treatmentBuprenorphineAdverse effectsSubstance useVulnerable populationsIndividual-level factorsMedicationsAccess challengesWhite participantsDisordersThe Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review
Jegede O, De Aquino J, Hsaio C, Caldwell E, Funaro M, Petrakis I, Muvvala S. The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review. Journal Of Addiction Medicine 2024 DOI: 10.1097/adm.0000000000001356.Peer-Reviewed Original ResearchNonmedical opioid useOpioid use disorderOpioid useWithdrawal symptomsTreatment outcomesSymptoms prior to treatmentUse disorderRisk of precipitated withdrawalLow-dose buprenorphineSynthetic opioidsPotency synthetic opioidsConclusions Current evidencePrecipitated withdrawalRisk of overdoseDosing strategiesPharmacological interactionsClinical significanceDecreased riskWeb of ScienceOpioidInclusion criteriaCurrent evidenceClinical implicationsMOUDPain